Exploring the association between inflammatory biomarkers and gastric cancer development: A two-sample mendelian randomization analysis.

Wenjing Yang,Ye Lv,Tao Ma,Ningju Wang,Ping Chen,Quanxia Liu,Hui Yan

DOI: https://doi.org/10.1097/md.0000000000036458

IF: 1.6

2024-02-03

Medicine

Abstract:Stomach cancer, known for its alarming prevalence and mortality, stands as the fifth most diagnosed malignancy globally and occupies the third position in cancer-related mortality as per the World Health Organization. [ 1 , 2 ] The geographic disparity in incidence rates is pronounced, with East Asian nations like China, Japan, and South Korea experiencing heightened rates, [ 3 , 4 ] in stark contrast to the lower incidences observed in North America and select European regions. The male population bears a disproportionately higher burden of this disease, [ 5–7 ] which may stem from gender-specific variations in diet, lifestyle, and genetic factors. Furthermore, the age-related trends in gastric cancer are noteworthy, with incidences predominantly escalating in individuals over the age of 50, affecting mainly the middle-aged and senior demographics. The complications associated with this cancer type, such as local invasion, metastasis, and gastrointestinal disturbances like bleeding, obstruction, and perforation, are of significant clinical concern. [ 8–10 ] The infiltrative growth nature of stomach cancer facilitates the tumor's encroachment into adjacent tissues, often leading to severe outcomes including bleeding and gastric perforation. [ 11 ] Metastatic spread, primarily through lymphatics and the bloodstream to organs such as the liver, lungs, and bones, exacerbates organ dysfunction, severely diminishing affected patients' life quality. [ 12 ]

medicine, general & internal